Chiriboga, Claudia A.
Columbia University Irving Medical Center
3 papers on CoChatORCID 0000-0001-6088-4889
Most cited papers
- Verified
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Finkel, R. S., Mercuri, E., Darras, B. T., Connolly, A. M., Kuntz, N. L., Kirschner, J., Chiriboga, C. A., Saito, K., Servais, L., Tizzano, E., et al. (2017) · New England Journal of Medicine
Neurogenetic and Muscular Disorders ResearchAmyotrophic Lateral Sclerosis Research
Cited by 2,337
- Verified
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., Iannaccone, S. T., Kirschner, J., Kuntz, N. L., Saito, K., et al. (2018) · New England Journal of Medicine
Neurogenetic and Muscular Disorders ResearchLysosomal Storage Disorders Research
Cited by 1,433
- Verified
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
Day, J. W., Finkel, R. S., Chiriboga, C. A., Connolly, A. M., Crawford, T. O., Darras, B. T., Iannaccone, S. T., Kuntz, N. L., Peña, L. D. M., Shieh, P. B., et al. (2021) · The Lancet Neurology
Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy research
Cited by 494
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free